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An avian-origin influenza A (H7N9) virus was a cause for concern in China in the spring
of 2013. Most H7N9 infections resulted in acute respiratory distress syndrome (ARDS),
which is a severe form of acute lung injury (ALI) that contributes to morbidity and
mortality. In this study, we induced viral ALI by infecting wild-type and CCL2-deficient
mice with influenza H7N9 virus. The results suggested a close association between C-C
motif chemokine ligand 2 (CCL2) expressions and ALI induced by a lethal H7N9 virus
strain (A/Hebei/01/2013). Elevated CCL2 levels were also detected in confirmed human
cases of H7N9 and the bronchoalveolar lavage fluid (BALF) of H7N9-infected mice.
Moreover, CCL2 was overexpressed in the lung tissue of infected mice. More importantly,
CCL2 deficiency ameliorated H7N9-induced ALI in mice as determined by weight loss,
survival rate, the wet:dry ratio of the lung, and pathology. Taken together, our findings
demonstrate that CCL2 is essential for H7N9 virus infection and thus that it is a potential
therapeutic target for influenza.
Keywords: lethal influenza H7N9 virus, acute lung injury (ALI), CCL2, experimental mouse model, influenza H7N9
Hb01 virus
INTRODUCTION
The influenza pandemic caused by avian influenza A (H7N9) was a cause for concern in eastern
China beginning inMarch 2013(Watanabe et al., 2013; Zhu et al., 2013). H7N9 infection resulted in
fever and cough, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS), which
frequently required admission to an intensive care unit (ICU); moreover, it was associated with
considerable morbidity and mortality (Chen et al., 2013). As of July 19, 2016, a total of 793 cases
had been reported, including 319 deaths (Xiang et al., 2017).
Most infected patients have exhibited excessive cytokine and chemokine production, which
could result in hypercytokinemia and is associated with disease severity (Chen et al., 2013; Chi
et al., 2013; Huang et al., 2014; Guo et al., 2015). Hypercytokinemia, also known as a “cytokine
storm,” is an early indicator of H7N9-induced ALI. However, the relationship between cytokine
production and the pathogenicity of H7N9 is unclear. C-C motif chemokine ligand 2 (CCL2), also
known as monocyte chemoattractant protein (MCP)-1, binds to the chemokine receptors CCR2
and CCR5, and is an important regulator of monocyte/macrophage trafficking during infection or
in the presence of inflammation (Takahashi et al., 2003; Herold et al., 2006; Yadav et al., 2010).
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Previous studies have shown that CCL2 plays a crucial role in
influenza virus H1N1 infection (Maelfait et al., 2016). Although
increased expression of CCL2 during influenza infection has
been well-documented (Zhou et al., 2013; Guo et al., 2015),
the effects of the CCL2/CCR2 pathway on the pathogenesis of
infection are controversial (Dawson et al., 2000; Narasaraju et al.,
2010; Maelfait et al., 2016). Thus, we determined the effects of
CCL2 on the severity of H7N9-induced ALI in an experimental
mouse model. We hypothesized that CCL2 participates in the
pathogenesis of the fulminant phase of H7N9-induced ALI and
may be a useful therapeutic target.
MATERIALS AND METHODS
Animals and Virus
Specific-pathogen-free (SPF), 4-week-old, wild-type C57BL/6
(B6) mice were obtained from the Experimental Animal
Center of the Academy of Military Medical Sciences (AMMS),
Beijing, China. SPF, 4-week-old, CCL2-deficient (CCL2−/−)
mice (Jackson Laboratories) were housed at the animal facility
of the Beijing Institute of Microbiology and Epidemiology in
accordance with institutional guidelines. The influenza A H7N9
virus strain A/Hebei/01/2013 (Hb01) was initially isolated from
a throat-swab specimen of a confirmed H7N9-infected patient in
Beijing and propagated by inoculation into SPF 9- to 11-day-old
embryonated eggs by the allantoic route. The accession numbers
of Hb01 in the GISAID database are EPI509120–EPI509127.
All experimental protocols involving animals were approved
by the Institutional Animal Care and Use Committee of the
AMMS (ID: SYXK2012-05), and all procedures conformed to
the relevant regulatory standards. All experiments involving live
virus were performed in an approved biosafety level 3 facility.
Experimental Mouse Models of Lethal
H7N9-Induced Acute Lung Injury
SPF, 4-week-old B6 mice were anesthetized with 40 mg/kg 1%
(w/v) pentobarbital sodium and received 103 of the 50% tissue
culture infectious dose (TCID50) of Hb01 virus in 20µL allantoic
fluid (AF) or an identical volume of control AF intranasally. The
survival rate, changes in body weight, histological parameters,
and acute lung edema (wet:dry ratio) were evaluated as described
previously (Li et al., 2012). Lung tissues were collected in 10%
neutral-buffered formalin and stained with hematoxylin and
eosin (H&E). The number of infiltrating inflammatory cells was
counted and presented as the number of cells per 200× field. The
analyses were performed in a blinded fashion.
Cytokine and Chemokine Measurement
Serum and bronchoalveolar lavage fluid (BALF) samples
were collected from the infected mice at indicated time
points. For cytokine and chemokine measurements, serum
and BALF samples were processed using the Bio-Plex Mouse
Cytokine 23-Plex instrument (Bio-Rad Laboratories) following
the manufacturer’s instructions, and array analyses were
performed using a Bio-Plex Protein Array system (Bio-Rad
Laboratories).
Measurement of Patient Serum Levels of
CCL2
The CCL2 levels in serum samples from 29 human patients
infected with H7N9 were measured using a Bio-Plex Human
Cytokine 25-Plex array (Bio-Rad Laboratories). Subjects
provided written informed consent for participation in this
study.
Confocal Fluorescence Microscopy
The lung tissues of mice were harvested, fixed in 10% formalin,
and processed for immunohistochemistry. A rabbit anti-mouse
CCL2 polyclonal antibody (Cell Signaling Technology, USA) and
goat anti-rabbit IgG-Alexa Fluor 488 (Bioss, Beijing) antibody
were used for immunohistochemistry. Nuclei were stained with
DAPI (Vector Labs), and visualized using a confocal laser
scanning microscope (FV1000, Olympus).
Statistical Analyses
All data are presented as means ± SEM. Statistical analyses were
performed using Student’s t-tests. Survival data were analyzed
using the Kaplan-Meier method, and single time points were
subjected to analysis of variance (ANOVA). All analyses were
performed using Instat software (version 5.0, GraphPad). A value
of p < 0.05 was taken to indicate statistical significance.
RESULTS
Mice Infected with Influenza H7N9 Virus
Hb01 Develop Severe ALI
To evaluate the pathogenicity of influenza H7N9 virus Hb01,
4-week-old C57BL/6 mice were inoculated intranasally (i.n.)
with 103 TCID50 Hb01. The mice began to die at 5 days post-
infection (DPI), and almost all had died by 10 DPI (Figure 1A).
All of the infected mice showed significant weight loss of up
to 30%, particularly at 9–11 DPI (Figure 1B). Moreover, lung
edema, defined as the wet:dry ratio of lung tissue, was observed
following Hb01 infection (Figure 1C). In addition, we evaluated
histological changes in lung tissues and found that histopathology
worsened significantly at 5 DPI (Figure 1D). Multiple leukocyte
infiltrations were detected in lung tissue, but there were no
significant histological changes in the intestine, brain, or kidney
tissues (Figure S1). By contrast, there were less numbers of
leukocytes in the BALF of CCL2-deficient mice (data not shown).
Taken together, these data indicate that 4-week-old C57 mice
infected with Hb01 have potential as an animal model of severe
2013 influenza H7N9 infection.
Cytokine Responses in Mice Infected with
Influenza H7N9 Hb01 Virus
Most patients infected with influenza H7N9 virus exhibit
hypercytokinemia, which leads to influenza virus-induced ALI
(Zhou et al., 2013). The levels of 23 cytokines and chemokines
in mouse BALF and serum at 5 DPI were investigated; IL-1α, IL-
2, MIP-1β, and GM-CSF levels were significantly upregulated in
serum but were unchanged in BALF. In addition, IL-4, IL-5, and
IL-13 levels were upregulated in BALF but were unchanged in
serum. IL-12(p40), IL-17, G-CSF, MIP-1α, IFN-γ, RANTES, and
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FIGURE 1 | Influenza H7N9 Hb01-induced ALI in mice. Four-week-old B6 mice were anesthetized and inoculated with 103 TCID50 Hb01 virus in 20 µL allantoic
fluid (AF) or an identical volume of control AF. Survival rates (A) and body weight changes (B) of B6 mice (n = 10) inoculated with AF and Hb01. Wet:dry ratios (C) of
mouse lung tissues (n = 6) at 5 DPI. H&E-stained images (D) and infiltrating cell counts (n = 100 fields) of the lung tissues of infected mice at 5 DPI (magnification =
200×). ***p < 0.001.
CCL2 levels were significantly upregulated in serum and BALF
upon H7N9 challenge (Figure 2, Figure S2). Strikingly, CCL2
levels in both BALF and serum remained high following H7N9
infection.
CCL2 Is Significantly Upregulated
following Influenza H7N9 Virus Infection
During the 2013 H7N9 influenza pandemic, we recruited 29
patients (Table S1) who were PCR-positive for H7N9, together
with 17 healthy individuals, from Quanzhou Hospital, Beijing
302 Hospital, and Beijing Chaoyang Hospital. The plasma
concentrations of CCL2 of the confirmedH7N9-infected patients
were significantly elevated compared to the control group
(Figure 3A), confirming previous reports (Zhou et al., 2013;
Guo et al., 2015). Similarly, CCL2 was significantly upregulated
beginning at 1 DPI in mouse BALF (Figure 3B) and serum
(Figure S3), and remained high in BALF up to 9DPI (Figure 3B);
indeed, it remained high in mouse serum following Hb01
infection (Figure S3). Furthermore, the lung tissues of mice
exhibited a high level of CCL2 at 5 DPI (Figure 3C). Thus, we
hypothesized that CCL2 might play a critical role in the host
response to lethal influenza H7N9 virus infection.
CCL2-Deficient Mice Exhibit Reduced
Severity of H7N9 Virus-Induced ALI
To elucidate the functional role of CCL2 in ALI, CCL2-
deficient mice were infected with lethal influenza H7N9 virus
Hb01; survival was significantly improved compared to infected
wild-type mice (Figure 4A). Rapid and irreversible weight
loss (>20%) occurred in infected wild-type control mice but
not in CCL2−/− mice following infection (Figure 4B). In
addition, lung edema was significantly ameliorated in infected
CCL2−/− mice (Figure 4C). Moreover, lung histopathology was
significantly improved and leukocyte infiltration of lung tissue
was significantly ameliorated in CCL2−/− mice (Figure 4D).
No pathologic changes were evident in the kidney, intestine,
or brain tissues of Hb01-infected mice (Figure S1). These
results confirm the important role of CCL2 in H7N9-induced
ALI, and suggest that this factor is a potential therapeutic
target.
DISCUSSION
H7N9-infected patients tend to have longer hospital stays and a
higher mortality rate than H1N1-infected patients (Chen et al.,
2013). Moreover, influenza H7N9 virus is more pathogenic to
mice and ferrets than is seasonal influenza virus (Belser et al.,
2013; Watanabe et al., 2013; Yum et al., 2015). For example,
A/Anhui/01/H7N9/2013 (H7N9) induces severe respiratory
disease in mice but is not lethal (Zhao et al., 2014), suggesting
that H7N9 virus strains exhibit various levels of virulence in
animal models. The role of CCL2 in influenza infection has been
investigated, but the findings are controversial (Dawson et al.,
2000; Narasaraju et al., 2010; Maelfait et al., 2016). Elevated
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FIGURE 2 | Cytokine and chemokine levels in BALF of Hb01-infected mice. Cytokine and chemokine concentrations in mouse BALF (n = 6) at 5 days after
inoculation with 103 TCID50 Hb01 or an identical volume of allantoic fluid were determined using a Mouse Cytokine 23-Plex Array (Bio-Rad Laboratories). *p < 0.05,
**p < 0.01, and ***p < 0.001.
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FIGURE 3 | CCL2 levels were significantly increased in the serum of H7N9-infected patients and the BALF and lung tissues of Hb01-infected mice. The
serum concentration of CCL2 of H7N9-infected patients (n = 29) was determined using a Bio-Plex Human Cytokine 25-Plex array (Bio-Rad Laboratories) (A).
Four-week-old B6 mice were anesthetized and inoculated with 103 TCID50 Hb01 virus. The level of CCL2 in BALF (B) was assayed using a Mouse Cytokine 23-Plex
Array (Bio-Rad Laboratories) at the indicated time points. (C) The CCL2 level in mouse lung tissue at 5 days after Hb01 infection was evaluated by fluorescence
microscopy. CCL2 was stained with Alexa Flour 488 (green) and nuclei were strained with DAPI (blue). *p < 0.05.
CCL2 levels in patients infected with H7N9 virus have also been
documented (Zhou et al., 2013; Guo et al., 2015). To the best
of our knowledge, this is the first report of the impact of CCL2
deficiency in H7N9-infected mice.
Influenza H7N9 patients die not due to the infection itself
but from ARDS caused by a cytokine storm, which is defined
as a release of excessive levels of more than 150 inflammatory
mediators (cytokines, oxygen free radicals, and coagulation
factors). Our data indicate that the levels of vital proinflammatory
cytokines and chemokines (including IL-12(p40), IL-17, G-CSF,
MIP-1α, IFN-γ, and RANTES) were significantly increased in the
BALF and serum of Hb01-virus infected mice. More importantly,
the levels of cytokines and chemokines in BALF were higher than
those in serum, likely because the lung is the target organ of
influenza virus infection.
CCL2 is significantly up-regulated during H1N1, H5N1,
and H7N9 infections (Li et al., 2012; Zhou et al., 2013; Lai
et al., 2014). In addition, CCL2 plasma levels could reflect
the severity of disease and predict fatal outcomes in patients
infected with H7N9 (Diao et al., 2014; Qian et al., 2014;
Guo et al., 2015). In this study, CCL2 levels were elevated in
mouse BALF, serum, and lung tissues following H7N9 infection,
in agreement with the increased levels in serum samples of
confirmed H7N9-infected patients. In addition, Dawson et al.
and other groups have reported that amelioration of CCL2
or CCR2 deficiency could protect mice from H1N1 infection
(Dawson et al., 2000; Kok et al., 2012; Maelfait et al., 2016).
However, CCL2 deficiency or CCL2 antibody treatment enhances
damage and impedes repair of the alveolar epithelium after
infection with a sublethal dose of influenza A virus or mouse-
adapted human influenza virus (Dessing et al., 2007; Narasaraju
et al., 2010). Of note, we investigated the role of CCL2 in
ALI induced by H7N9 virus; CCL2 deficiency protected mice
from lethal influenza H7N9 virus infection. CCL2−/− mice
showed less weight loss, a lower mortality rate, improved
lung edema, and ameliorated histopathological changes post-
infection.
The innate immune response acts as the first line of defense
against pathogenic agents. Previous studies have revealed that
innate immunity is essential for H5N1-induced ALI (Sun
et al., 2012). Innate immunity plays a key role in resistance
to influenza infection, but an excessive response is harmful
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FIGURE 4 | CCL2−/− mice exhibited reduced severity of lung injury. Four-week-old CCL2−/− and wild-type B6 mice were inoculated with 103 TCID50 Hb01
virus. Survival rates (A) and body weight changes (B) of wild-type and CCL2−/− mice (n = 10) were monitored for 2 weeks after Hb01 challenge. Wet:dry ratios (C) of
lung tissues (n = 6) at 5 DPI. HE-stained images (D) and infiltrating cell counts (n = 100 fields) of lung tissues at 5 DPI (magnification = 200×). *p < 0.05, **p < 0.01,
and ***p < 0.001.
to the host. Infiltration of inflammatory cells, particularly
monocytes/macrophages, in the lung leads to the generation of
a cytokine storm. Similarly, in another experiment, we found
that Rag 1-knockout mice function in the course of lethal
H7N9 induced-ALI in mice, indicating that the innate immune
response plays a crucial role during influenza H7N9 virus
infection (data not shown here). In addition, the viral titer
in CCL2-null mice, and the effects of anti-CCL2 therapy of
wild-type mice subjected to H7N9 infection, warrant further
investigation. Such studies will likely confirm that CCL2 is a
crucial mediator of the inflammatory response during H7N9
infection or is it affecting in some way the viral burden. We
believe that clinical intervention using an appropriate immune
modulator combined with antiviral treatment would benefit
H7N9 patients.
In conclusion, mice infected with influenza H7N9 Hb01
virus exhibited severe ALI and other symptoms typical of
influenza. Our data demonstrate an association between CCL2
expression and a severe form of ALI induced by H7N9 infection
in mice. Therefore, CCL2 is a pivotal mediator in H7N9
infection and should be considered a promising therapeutic
target.
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Figure S1 | HE-stained images of the brain, kidney, and intestine of
Hb01-infected mice. Four-week-old wild-type B6 and CCL2−/− mice were
inoculated with control AF or 103 TCID50 Hb01 virus. The brain, kidney, and
intestine of mice were harvested at 5 DPI and subjected to histopathological
analysis (magnification = 200×).
Figure S2 | Serum levels of cytokines and chemokines of Hb01-infected
mice. Mouse Serum levels of cytokines and chemokines in mice (n = 6) at 5 days
after inoculation with 103 TCID50 Hb01 or an identical volume of allantoic fluid
were determined using a Mouse Cytokine 23-Plex Array (Bio-Rad Laboratories).
∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Figure S3 | Serum levels of CCL2 in Hb01-infected mice. Four-week-old B6
mice were anesthetized and inoculated with 103 TCID50 Hb01 virus. Serum levels
of CCL2 (n = 6) were determined using a Mouse Cytokine 23-Plex Array (Bio-Rad
Laboratories) at the indicated time points.
Table S1 | Basic characteristics of patient recruited.
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